


Qiming Venture Partners
Venture Capital and Private Equity Principals • Room 3901 Jinmao Tower, 88 Century Boulevard, Hong Kong • 101-200 Employees
Company overview
| Headquarters | Room 3901 Jinmao Tower, 88 Century Boulevard, Hong Kong, HK |
| Phone number | +852862161016522 |
| Website | |
| NAICS | 52391 |
| SIC | 679 |
| Keywords | Venture Capital, Consumer, Technology, Healthcare, China, Investment, TMT |
| Founded | 2006 |
| Employees | 101-200 |
| Socials |
Key Contacts at Qiming Venture Partners
Vivian Deng
Ir Director - Usd Funds
Raymond Wong
Associate Tax Director
Michael Chiu
Director Of Strategy And Research
Mia Lau
Associate Finance Director
飞 米
Ga Director
Qiming Venture Partners Email Formats
Qiming Venture Partners uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@qimingvc.com), used 54.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@qimingvc.com | 54.2% |
{first name}{last name} | johndoe@qimingvc.com | 37.5% |
{first initial}.{last name} | j.doe@qimingvc.com | 8.3% |
About Qiming Venture Partners
Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages. Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 80 portfolio companies that have achieved unicorn or super unicorn status. Many of our portfolio companies are today's most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Zhihu (NYSE:ZH, SEHK:2390), Roborock (SHSE:688169), UBTech (SEHK:9880), WeRide (NASDAQ:WRD), Insta360 (SHSE:688775), Gan & Lee Pharmaceuticals (SHSE:603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), Sanyou Medical (SHSE:688085), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE:688520), Yuanxin Technology, Insilico Medicine, Medilink Therapeutics, LaNova Medicines, Zhipu, StepFun, among many others.
Qiming Venture Partners revenue & valuation
| Annual revenue | $32,000,000 |
| Revenue per employee | $272,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Venture Capital and Private Equity Principals industry and current estimated revenues | $102,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Qiming Venture Partners has 36 employees across 6 departments.
Departments
Number of employees
Funding Data
Qiming Venture Partners has never raised funding before.
Qiming Venture Partners Tech Stack
Discover the technologies and tools that power Qiming Venture Partners's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Reverse proxies
Programming languages
CMS
JavaScript libraries
SSL/TLS certificate authorities
Frequently asked questions
4.8
40,000 users



